Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
A breakthrough study reveals that semaglutide, found in Ozempic and Wegovy, could help reduce alcohol cravings and heavy ...
A new study has found that semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with AUD. Despite the availability of treatment options ...
Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss ...
Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results